Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
About this item
Full title
Author / Creator
Publisher
Switzerland: Frontiers Research Foundation
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: Frontiers Research Foundation
Subjects
More information
Scope and Contents
Contents
To examine the prospective association between blood biomarkers of immune functioning (i.e., innate immune activation, adaptive immunity, and inflammation) and subsequent cognitive decline and clinical progression to mild cognitive impairment (MCI) in cognitively normal individuals.
The BIOCARD study is an observational cohort study of
= 191...
Alternative Titles
Full title
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_48782f6672544e428d6d590be8c029ec
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_48782f6672544e428d6d590be8c029ec
Other Identifiers
ISSN
1663-4365
E-ISSN
1663-4365
DOI
10.3389/fnagi.2019.00229
